EUVIMEDEUVIMED entdecken
Open Access

Shedding new light on RhoA signalling as a drug target in vivo using a novel RhoA-FRET biosensor mouse

Max Nobis iD, David Herrmann iD, Sean C Warren iD, Douglas Strathdee iD, Thomas R Cox iD, Kurt I Anderson iD, Paul Timpson iD

Small GTPases · 03.07.2020 · 11 (4) · 240-247

DOI: 10.1080/21541248.2018.1438024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small GTPases, online erschienen am 21.03.2018. Verfasst von Max Nobis und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Garvan Institute of Medical Research, St Vincent's Clinical School, Faculty of Medicine, University of New South Wales , Sydney, 2010 NSW, Austra…. Hauptthemen laut MEDLINE: Biosensing Techniques, Fluorescence Resonance Energy Transfer. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Cancer Research UK, National Breast Cancer Foundation, National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The small GTPase RhoA is a master regulator of signalling in cell-extracellular matrix interactions. RhoA signalling is critical to many cellular processes including migration, mechanotransduction, and is often disrupted in carcinogenesis. Investigating RhoA activity in a native tissue environment is challenging using conventional biochemical methods; we therefore developed a RhoA-FRET biosensor mouse, employing the adaptable nature of intravital imaging to a variety of settings. Mechanotransduction was explored in the context of osteocyte processes embedded in the calvaria responding in a directional manner to compression stress. Further, the migration of neutrophils was examined during in vivo "chemotaxis" in wound response. RhoA activity was tightly regulated during tissue remodelling in mammary gestation, as well as during mammary and pancreatic carcinogenesis. Finally, pharmacological inhibition of RhoA was temporally resolved by the use of optical imaging windows in fully developed pancreatic and mammary tumours in vivo. The RhoA-FRET mouse therefore constitutes a powerful tool to facilitate development of new inhibitors targeting the RhoA signalling axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biosensing TechniquesFluorescence Resonance Energy TransferAnimalsMicePharmaceutical PreparationsSignal TransductionrhoA GTP-Binding Protein

Stichwörter der Autor:innen

FLIMFRETIntravital imagingRho-GTPasesRhoAbiosensorsbreast cancerextracellular matrixpancreatic cancer

Substanzen

Pharmaceutical PreparationsRhoA protein, mouserhoA GTP-Binding Protein

Autor:innen und Institutionen

  • The Garvan Institute of Medical Research, St Vincent's Clinical School, Faculty of Medicine, University of New South Wales , Sydney, 2010 NSW, Australia.
  • Cancer Research UK Beatson Institute, Switchback Road , Bearsden, Glasgow G611BD, UK.
  • Francis Crick Institute , London NW11AT, UK.

ORCID-Profile: Max Nobis, David Herrmann, Sean C Warren, Douglas Strathdee, Thomas R Cox, Kurt I Anderson, Paul Timpson

Förderung

  • Cancer Research UK
  • National Breast Cancer Foundation
  • National Health and Medical Research Council
  • Cancer Institute New South Wales Early Carrer Fellowship
  • Cancer Council NSW
  • LEN AINSWORTH PANCREATIC CANCER
  • Sydney Catalyst
  • Tour de Cure

Zitieren

APA

Nobis, M., Herrmann, D., Warren, S. C., Strathdee, D., Cox, T. R., Anderson, K. I., & Timpson, P. (2020). Shedding new light on RhoA signalling as a drug target in vivo using a novel RhoA-FRET biosensor mouse. Small GTPases, 11(4), 240-247. https://doi.org/10.1080/21541248.2018.1438024

Vancouver

Nobis M, Herrmann D, Warren SC, Strathdee D, Cox TR, Anderson KI, et al. Shedding new light on RhoA signalling as a drug target in vivo using a novel RhoA-FRET biosensor mouse. Small GTPases. 2020;11(4):240-247. doi:10.1080/21541248.2018.1438024

BibTeX
@article{Nobis2020,
  author = {Nobis, Max and Herrmann, David and Warren, Sean C and Strathdee, Douglas and Cox, Thomas R and Anderson, Kurt I and Timpson, Paul},
  title = {Shedding new light on RhoA signalling as a drug target in vivo using a novel RhoA-FRET biosensor mouse},
  journal = {Small GTPases},
  year = {2020},
  volume = {11},
  number = {4},
  pages = {240--247},
  doi = {10.1080/21541248.2018.1438024}
}
Kostenlos starten →